The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Agios; Amgen; Astellas Oncology; Celgene; Cellectis; Daiichi Sankyo; Incyte; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Menarini; Novartis; Pfizer; Seagen; SERVIER; Sunesis Pharmaceuticals
Research Funding - Amgen; Incyte; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer
 
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Pfizer
Research Funding - Novartis
Long-term survival of adults with B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) after treatment with blinatumomab and subsequent allogeneic hematopoietic stem cell transplantation (HSCT).
 
Max Topp
Honoraria - Amgen
Consulting or Advisory Role - Affimed Therapeutics; Amgen; Gilead Sciences; Jazz Pharmaceuticals; Regeneron; Roche
Speakers' Bureau - Amgen
Research Funding - Affimed Therapeutics; Amgen; Regeneron; Roche
Patents, Royalties, Other Intellectual Property - Biomarkers for Immunotherapies
Expert Testimony - Affimed Therapeutics; Amgen; Boehringer Ingelheim; Regeneron
Travel, Accommodations, Expenses - Affimed Therapeutics; Amgen; Roche
 
Anthony Selwyn Stein
Speakers' Bureau - Amgen; Celgene
 
Gerhard Zugmaier
Employment - Amgen
Leadership - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Hervé Dombret
No Relationships to Disclose
 
Monika Brueggemann
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Incyte; PRMA Consulting
Speakers' Bureau - Amgen; Pfizer; Roche
Research Funding - Amgen
 
Massimiliano Bonifacio
No Relationships to Disclose
 
Xiaoyu Dong
Employment - Amgen
Stock and Other Ownership Interests - Amgen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Amgen
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Amgen; ARIAD; Bristol-Myers Squibb; ImmunoGen; Orsenix; Pfizer
Research Funding - Amgen; ARIAD; Astex Pharmaceuticals; Bristol-Myers Squibb; Novartis; Pfizer
 
Ralf C. Bargou
Honoraria - Amgen; Genmab; Novartis
Consulting or Advisory Role - Amgen; Genmab; Novartis
Patents, Royalties, Other Intellectual Property - Amgen
 
Nicola Gökbuget
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen